Sonia Zevallos-Bustamante
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Sonia Zevallos-Bustamante has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Paulo Ruiz-Grosso
Instituto Nacional de Salud Mental "Honorio Delgado-Hideyo Noguchi
4 shared publications - Abel Ampelio Ii Sagástegui Soto
Instituto Nacional de Salud Mental "Honorio Delgado-Hideyo Noguchi", Lima, Peru
3 shared publications - Luis Macedo-Orrego
Instituto Nacional de Salud Mental "Honorio Delgado-Hideyo Noguchi
3 shared publications - Alejandra Arosemena Aliaga
Instituto Nacional de Salud Mental "Honorio Delgado-Hideyo Noguchi", Lima, Peru
2 shared publications - Diego Mauricio Rodríguez Vargas
Instituto Nacional de Salud Mental "Honorio Delgado-Hideyo Noguchi", Lima, Peru
2 shared publications - Maria Carazas-Vera
Instituto Nacional de Salud Mental "Honorio Delgado-Hideyo Noguchi", Lima, Peru
2 shared publications
Latest Publications
- Open Access
Longitudinal changes in dose-normalized psychotropic medication exposure around transfer to a specialized older adult mental health service: a retrospective longitudinal study in Peru
Objectives: This research aimed to characterize longitudinal changes in dose-normalized psychotropic exposure around transfer to a specialized older adult mental health service in Peru, with the primary contrast comparing the last eligible pre-transfer consultation (T0) with six months after transfer. We additionally explored characteristics associated with average medication-score levels and potential modification of the T0-to-6-month change. Methods: A retrospective longitudinal single-cohort study was conducted using routine clinical records from the Instituto Nacional de Salud Mental Honorio Delgado-Hideyo Noguchi in Lima, Peru. The primary analytic cohort comprised patients transferred to the older adult service who had valid longitudinal medication data at or before transfer and after transfer. A dose-normalized psychotropic medication score was calculated at approximately -6 months, -3 months, T0 (the last eligible consultation before transfer), +3 months, and +6 months. Longitudinal change was estimated using linear mixed-effects models with categorical time and participant-specific random intercepts; the prespecified primary contrast compared +6 months with T0. Sensitivity analyses evaluated alternative score definitions, age restrictions, influential observations, and participant-level cluster bootstrap resampling. Results: The primary analytic cohort included 213 participants; mean age at T0 was 65.5 years (SD 7.2), 59.2% were female, and the most frequent diagnostic categories were psychotic disorders (52.1%) and depressive disorders (29.1%). The medication score was 17.87 points higher at +6 months than at T0 (95% CI 12.18 to 23.57; p < 0.001), and the exploratory adjusted estimate was similar (17.82 points; 95% CI 12.10 to 23.54; p < 0.001). The primary contrast remained positive across alternative score definitions, age-restricted analyses, influence analyses, and participant-level bootstrap resampling. In exploratory effect-modification analyses, each 10-year increase in age was associated with a 10.94-point greater T0-to-+6-month change (95% CI 2.33 to 19.55; p = 0.013), although this association did not remain statistically significant after false-discovery-rate correction (FDR-adjusted p = 0.091); no other tested modifier showed evidence of interaction after FDR correction. Conclusions: Dose-normalized prescribed psychotropic exposure increased from a relative pre-transfer low point at T0 to 6 months after transfer, with similar estimates across sensitivity analyses. In the absence of a contemporaneous comparison group, this finding should be interpreted as a temporal association around service transfer rather than evidence that transfer itself caused the increase or that the resulting prescribing was clinically beneficial, harmful, or inappropriate.
Open AccessLongitudinal changes in dose-normalized psychotropic medication exposure around transfer to a specialized older adult mental health service: a retrospective longitudinal study in Peru
Objectives: This research aimed to characterize longitudinal changes in dose-normalized psychotropic exposure around transfer to a specialized older adult mental health service in Peru, with the primary contrast comparing the last eligible pre-transfer consultation (T0) with six months after transfer. We additionally explored characteristics associated with average medication-score levels and potential modification of the T0-to-6-month change. Methods: A retrospective longitudinal single-cohort study was conducted using routine clinical records from the Instituto Nacional de Salud Mental Honorio Delgado-Hideyo Noguchi in Lima, Peru. The primary analytic cohort comprised patients transferred to the older adult service who had valid longitudinal medication data at or before transfer and after transfer. A dose-normalized psychotropic medication score was calculated at approximately -6 months, -3 months, T0 (the last eligible consultation before transfer), +3 months, and +6 months. Longitudinal change was estimated using linear mixed-effects models with categorical time and participant-specific random intercepts; the prespecified primary contrast compared +6 months with T0. Sensitivity analyses evaluated alternative score definitions, age restrictions, influential observations, and participant-level cluster bootstrap resampling. Results: The primary analytic cohort included 213 participants; mean age at T0 was 65.5 years (SD 7.2), 59.2% were female, and the most frequent diagnostic categories were psychotic disorders (52.1%) and depressive disorders (29.1%). The medication score was 17.87 points higher at +6 months than at T0 (95% CI 12.18 to 23.57; p < 0.001), and the exploratory adjusted estimate was similar (17.82 points; 95% CI 12.10 to 23.54; p < 0.001). The primary contrast remained positive across alternative score definitions, age-restricted analyses, influence analyses, and participant-level bootstrap resampling. In exploratory effect-modification analyses, each 10-year increase in age was associated with a 10.94-point greater T0-to-+6-month change (95% CI 2.33 to 19.55; p = 0.013), although this association did not remain statistically significant after false-discovery-rate correction (FDR-adjusted p = 0.091); no other tested modifier showed evidence of interaction after FDR correction. Conclusions: Dose-normalized prescribed psychotropic exposure increased from a relative pre-transfer low point at T0 to 6 months after transfer, with similar estimates across sensitivity analyses. In the absence of a contemporaneous comparison group, this finding should be interpreted as a temporal association around service transfer rather than evidence that transfer itself caused the increase or that the resulting prescribing was clinically beneficial, harmful, or inappropriate.
- Open Access
Virtual and In-Person Psychiatric Care: Appointment Completion and Capacity Use in a Public Mental Health Service in Peru
Objective: To compare appointment completion and offered-slot utilization between virtual and in-person outpatient psychiatric care in Peru. Methods: We conducted a retrospective ecological longitudinal study using routinely collected monthly aggregate administrative indicators from January 2022 through June 2026, with modality-month as the unit. Virtual-minus-in-person differences and 95% confidence intervals used Newey-West standard errors with 12 lags. June 2026 was partial; slot utilization was restricted to 2024-2026. Results: Across 54 paired months, mean completion was 90.9% (SD=3.9) for virtual and 83.8% (SD=2.7) for in-person care; difference +7.2 points (95% CI=4.4-9.9). Across 30 paired months, slot utilization was 73.0% (SD=8.3) and 90.5% (SD=3.8), respectively; difference −17.5 points (95% CI=−24.5 to −10.4). Sensitivity analyses were similar. Conclusions: Virtual care had higher completion but lower slot utilization. Attendance and capacity use should be evaluated separately when planning hybrid psychiatric services. Outpatient psychiatric services increasingly operate as hybrid systems in which virtual and in-person visits coexist.
Open AccessVirtual and In-Person Psychiatric Care: Appointment Completion and Capacity Use in a Public Mental Health Service in Peru
Objective: To compare appointment completion and offered-slot utilization between virtual and in-person outpatient psychiatric care in Peru. Methods: We conducted a retrospective ecological longitudinal study using routinely collected monthly aggregate administrative indicators from January 2022 through June 2026, with modality-month as the unit. Virtual-minus-in-person differences and 95% confidence intervals used Newey-West standard errors with 12 lags. June 2026 was partial; slot utilization was restricted to 2024-2026. Results: Across 54 paired months, mean completion was 90.9% (SD=3.9) for virtual and 83.8% (SD=2.7) for in-person care; difference +7.2 points (95% CI=4.4-9.9). Across 30 paired months, slot utilization was 73.0% (SD=8.3) and 90.5% (SD=3.8), respectively; difference −17.5 points (95% CI=−24.5 to −10.4). Sensitivity analyses were similar. Conclusions: Virtual care had higher completion but lower slot utilization. Attendance and capacity use should be evaluated separately when planning hybrid psychiatric services. Outpatient psychiatric services increasingly operate as hybrid systems in which virtual and in-person visits coexist.
- Open Access
Mental health contact gaps among adults in Peru: a cross-sectional analysis of a nationally representative survey
Objective: To estimate lifetime and 12-month mental health contact gaps among Peruvian adults with survey-defined mental disorders, and to describe inequalities in contact, perceived need for care, and mental health service use. Methods: We analyzed the information for adults of the 2022 Peruvian National Mental Health Survey, a cross-sectional household survey. The primary outcome was the survey-weighted proportion of adults with a 12-month mental disorder who reported no contact with an included source of mental health-related care during that period; the lifetime contact gap was descriptive. Perceived need was assessed using two derived 12-month perceived-need measures based on direct ENSM variables and service-contact routing items. Analyses incorporated weights, strata, and clusters. Adjusted prevalence ratios were estimated using survey-weighted Poisson models. Results: The dataset contained information on 13,840 individuals; 13,833 had complete survey-design information. Contact-gap denominators were 3,927 for lifetime disorders and 1,649 for 12-month disorders. The lifetime and 12-month contact gaps were 61.0% (95% CI 58.4–63.7) and 84.5% (95% CI 81.5–87.6), respectively. Rural estimates exceeded urban estimates in both periods; after adjustment, poverty and rural residence were associated with the lifetime gap, and extreme poverty with the 12-month gap. Among individuals meeting survey-based criteria for one or more 12-month mental disorders, 37.3% (95% CI 33.4–41.4) reported self-perceived need, whereas 25.6% (95% CI 21.8–29.8) reported that need had been identified by others. Annual psychological and psychiatric service use was 3.7% and 1.1%, respectively. Conclusions: Mental health contact gaps were high, particularly for one or more 12-month mental disorders, and were associated with social and territorial variables. These contact measures do not establish adequate, continuous, or effective treatment; which need to be addressed to understand the impact of the Peruvian mental health reform.
Open AccessMental health contact gaps among adults in Peru: a cross-sectional analysis of a nationally representative survey
Objective: To estimate lifetime and 12-month mental health contact gaps among Peruvian adults with survey-defined mental disorders, and to describe inequalities in contact, perceived need for care, and mental health service use. Methods: We analyzed the information for adults of the 2022 Peruvian National Mental Health Survey, a cross-sectional household survey. The primary outcome was the survey-weighted proportion of adults with a 12-month mental disorder who reported no contact with an included source of mental health-related care during that period; the lifetime contact gap was descriptive. Perceived need was assessed using two derived 12-month perceived-need measures based on direct ENSM variables and service-contact routing items. Analyses incorporated weights, strata, and clusters. Adjusted prevalence ratios were estimated using survey-weighted Poisson models. Results: The dataset contained information on 13,840 individuals; 13,833 had complete survey-design information. Contact-gap denominators were 3,927 for lifetime disorders and 1,649 for 12-month disorders. The lifetime and 12-month contact gaps were 61.0% (95% CI 58.4–63.7) and 84.5% (95% CI 81.5–87.6), respectively. Rural estimates exceeded urban estimates in both periods; after adjustment, poverty and rural residence were associated with the lifetime gap, and extreme poverty with the 12-month gap. Among individuals meeting survey-based criteria for one or more 12-month mental disorders, 37.3% (95% CI 33.4–41.4) reported self-perceived need, whereas 25.6% (95% CI 21.8–29.8) reported that need had been identified by others. Annual psychological and psychiatric service use was 3.7% and 1.1%, respectively. Conclusions: Mental health contact gaps were high, particularly for one or more 12-month mental disorders, and were associated with social and territorial variables. These contact measures do not establish adequate, continuous, or effective treatment; which need to be addressed to understand the impact of the Peruvian mental health reform.
- Open Access
Loss to follow-up of ambulatory patients in the transition to telemedicine in the COVID-19 pandemic at a reference center for mental health in Lima, Peru
Problem Statement During the COVID-19 pandemic, health care services were limited by the restrictive measures implemented. As an adaptation mechanism, telemedicine was introduced for ambulatory care at the Honorio Delgado Hideyo Noguchi National Institute of Mental Health (NIMH). This study aimed to estimate the survival function (SF) for loss to follow-up (LTFU) over two years before and after the onset of the COVID-19 pandemic, and its association with clinical and sociodemographic variables. Study Design A single-cohort study was conducted, following a random sample of adult ambulatory patients at NIHM from April 15, 2018, to April 15, 2022. Patients were followed until LTFU, referral to another institution, death, or the end of study. The main analysis involved estimating the SF for LTFU for the overall follow up period, as well as separately for the periods pre and post implementation of telemedicine. Also, risk factors hypotheses were tested using Cox’s regression. Results Data from 4887 visits of 356 patients were collected. A total of 118 (33.1%) presented LTFU, with SF of 53.9% during the overall four years of follow-up. After two years of follow-, those starting treatment at NIMH before the implementation of telemedicine had a higher SF (77.3 vs 63%). A higher hazard ratio (HR) for LTFU was found in the group that started care at NIMH after the implementation of telemedicine, compared to those who started previously (HR=2.53; 95% CI: 1.55-4.51). Additionally, receiving care in the anxiety disorders (HR=1.86; 95% CI: 1.03-3.33) and personality disorders programs (HR=1.81; 95% CI: 1.02-3.22) was associated with a higher risk of LTFU compared to the psychosis program. No significant difference was found in the risk of LTFU between telemedicine vs. face-to face attention. Conclusions A significant association was found between LTFU and starting treatment at NIMH after the onset of the COVID-19 pandemic and implementation of telemedicine. However, no evidence supports that this might be due to the practice of telemedicine. A different clinical profile of patients that started treatment at NIMH following the government implementation of changes to the public health system might explain these findings and should be studied. Significant Outcomes - A moderate association was found between starting treatment at NIMH and loss to follow up in the period after the implementation of telemedicine due to the onset of COVID-19. - This, however, does not seem to be related to the practice of telemedicine, but to changes in the characteristics of patients across pre and post COVID 19. Limitations - The reason for loss to follow up (death, return to a lower-level health service, improvement of symptoms, etc.), our main outcome variable, could not be determined using the clinical and administrative data available.
Open AccessLoss to follow-up of ambulatory patients in the transition to telemedicine in the COVID-19 pandemic at a reference center for mental health in Lima, Peru
Problem Statement During the COVID-19 pandemic, health care services were limited by the restrictive measures implemented. As an adaptation mechanism, telemedicine was introduced for ambulatory care at the Honorio Delgado Hideyo Noguchi National Institute of Mental Health (NIMH). This study aimed to estimate the survival function (SF) for loss to follow-up (LTFU) over two years before and after the onset of the COVID-19 pandemic, and its association with clinical and sociodemographic variables. Study Design A single-cohort study was conducted, following a random sample of adult ambulatory patients at NIHM from April 15, 2018, to April 15, 2022. Patients were followed until LTFU, referral to another institution, death, or the end of study. The main analysis involved estimating the SF for LTFU for the overall follow up period, as well as separately for the periods pre and post implementation of telemedicine. Also, risk factors hypotheses were tested using Cox’s regression. Results Data from 4887 visits of 356 patients were collected. A total of 118 (33.1%) presented LTFU, with SF of 53.9% during the overall four years of follow-up. After two years of follow-, those starting treatment at NIMH before the implementation of telemedicine had a higher SF (77.3 vs 63%). A higher hazard ratio (HR) for LTFU was found in the group that started care at NIMH after the implementation of telemedicine, compared to those who started previously (HR=2.53; 95% CI: 1.55-4.51). Additionally, receiving care in the anxiety disorders (HR=1.86; 95% CI: 1.03-3.33) and personality disorders programs (HR=1.81; 95% CI: 1.02-3.22) was associated with a higher risk of LTFU compared to the psychosis program. No significant difference was found in the risk of LTFU between telemedicine vs. face-to face attention. Conclusions A significant association was found between LTFU and starting treatment at NIMH after the onset of the COVID-19 pandemic and implementation of telemedicine. However, no evidence supports that this might be due to the practice of telemedicine. A different clinical profile of patients that started treatment at NIMH following the government implementation of changes to the public health system might explain these findings and should be studied. Significant Outcomes - A moderate association was found between starting treatment at NIMH and loss to follow up in the period after the implementation of telemedicine due to the onset of COVID-19. - This, however, does not seem to be related to the practice of telemedicine, but to changes in the characteristics of patients across pre and post COVID 19. Limitations - The reason for loss to follow up (death, return to a lower-level health service, improvement of symptoms, etc.), our main outcome variable, could not be determined using the clinical and administrative data available.
- Open Access
- 3 August 2022
- Published by Fundacion Instituto Hipolito Unanue in Diagnóstico
- Vol. 61 (3) , e374
Estudio epidemiológico sobre el impacto de la pandemia COVID-19 en la salud mental de la población de Lima Metropolitana
Objetivo: Identificar en la población adulta de la Lima Metropolitana la prevalencia, acceso y factores asociados a los principales trastornos mentales (TM) durante la pandemia COVID-19. Metodología: Estudio transversal, correlacional en una muestra probabilística, bietápica, de 1823 personas adultas (≥18 años), entrevistada vía telefónica. Instrumentos: Ficha sociodemográfica y características de vivienda; Cuestionario sobre Experiencias COVID-19; la MINI International Neuropsychiatric Interview Versión CIE-10; la Escala de Riesgo Suicida del MINI; el Índice de Calidad de Sueño de Pittsburgh; Escala de Percepción de Estrés; Escala Breve de Funcionamiento Psicosocial (basada en áreas sugeridas del WHO DAS-S); Cuestionario sobre Acceso a Servicios de Salud; Índice de Calidad de Vida de Mezzich; Escala de Satisfacción con la Vida de Diener; Escala de Resiliencia del Yo de Block; y un Cuestionario Abreviado Ad-hoc sobre Violencia Doméstica. Se utilizó la F corregida como una variante del estadístico de chi-cuadrado corregido de Rao-Scott de segundo orden y análisis de regresión logística para muestras complejas. Resultados: Se encontró en un 57,2% de la población un nivel de estrés de moderado a severo. La mayoría de los indicadores de salud mental, incluyendo de salud positiva, mostraron resultados desfavorables con respecto a estudios previos, incluyendo indicadores suicidas, problemas de sueño y la violencia sistemática contra la mujer. La prevalencia a 12 meses, 6 meses y actual de algún TM fue del 19,6%, 17,8% y 12,5%, respectivamente. El TM más frecuente fue el episodio depresivo con una prevalencia anual de 13,6% y de 6 meses de 12,3%, seguido por el trastorno de ansiedad generalizada. La presencia de TM se asoció significativamente con el sexo femenino, menor edad, estado civil viudo(a), divorciado(a) o separado(a), un menor nivel educativo, baja situación económica, haber perdido el empleo por la pandemia, haberse contagiado de la COVID-19, tener un familiar contagiado y tener un familiar fallecido por COVID. De la misma manera las personas afectadas por la COVID-19 presentaron resultados desfavorables en los todos los indicadores de salud mental. El 12,2% de las personas con TM diagnosticables fue atendida, y 29,4% consideró haber necesitado bastante o mucha atención, pero no la recibió. Conclusiones: En comparación a períodos sin pandemia, se ha encontrado un incremento desfavorable de los indicadores de salud mental que obliga a asumir que uno de los principales efectos de la pandemia sería sobre la salud mental de las personas y, por lo tanto, las políticas sociales deberían orientarse con prioridad en este aspecto.
- 3 August 2022
- Published by Fundacion Instituto Hipolito Unanue in Diagnóstico
- Vol. 61 (3) , e374
Open AccessEstudio epidemiológico sobre el impacto de la pandemia COVID-19 en la salud mental de la población de Lima Metropolitana
Objetivo: Identificar en la población adulta de la Lima Metropolitana la prevalencia, acceso y factores asociados a los principales trastornos mentales (TM) durante la pandemia COVID-19. Metodología: Estudio transversal, correlacional en una muestra probabilística, bietápica, de 1823 personas adultas (≥18 años), entrevistada vía telefónica. Instrumentos: Ficha sociodemográfica y características de vivienda; Cuestionario sobre Experiencias COVID-19; la MINI International Neuropsychiatric Interview Versión CIE-10; la Escala de Riesgo Suicida del MINI; el Índice de Calidad de Sueño de Pittsburgh; Escala de Percepción de Estrés; Escala Breve de Funcionamiento Psicosocial (basada en áreas sugeridas del WHO DAS-S); Cuestionario sobre Acceso a Servicios de Salud; Índice de Calidad de Vida de Mezzich; Escala de Satisfacción con la Vida de Diener; Escala de Resiliencia del Yo de Block; y un Cuestionario Abreviado Ad-hoc sobre Violencia Doméstica. Se utilizó la F corregida como una variante del estadístico de chi-cuadrado corregido de Rao-Scott de segundo orden y análisis de regresión logística para muestras complejas. Resultados: Se encontró en un 57,2% de la población un nivel de estrés de moderado a severo. La mayoría de los indicadores de salud mental, incluyendo de salud positiva, mostraron resultados desfavorables con respecto a estudios previos, incluyendo indicadores suicidas, problemas de sueño y la violencia sistemática contra la mujer. La prevalencia a 12 meses, 6 meses y actual de algún TM fue del 19,6%, 17,8% y 12,5%, respectivamente. El TM más frecuente fue el episodio depresivo con una prevalencia anual de 13,6% y de 6 meses de 12,3%, seguido por el trastorno de ansiedad generalizada. La presencia de TM se asoció significativamente con el sexo femenino, menor edad, estado civil viudo(a), divorciado(a) o separado(a), un menor nivel educativo, baja situación económica, haber perdido el empleo por la pandemia, haberse contagiado de la COVID-19, tener un familiar contagiado y tener un familiar fallecido por COVID. De la misma manera las personas afectadas por la COVID-19 presentaron resultados desfavorables en los todos los indicadores de salud mental. El 12,2% de las personas con TM diagnosticables fue atendida, y 29,4% consideró haber necesitado bastante o mucha atención, pero no la recibió. Conclusiones: En comparación a períodos sin pandemia, se ha encontrado un incremento desfavorable de los indicadores de salud mental que obliga a asumir que uno de los principales efectos de la pandemia sería sobre la salud mental de las personas y, por lo tanto, las políticas sociales deberían orientarse con prioridad en este aspecto.